T. Rowe Price Associates

T. Rowe Price Associates’s ESSA Pharma EPIX Stock Holding History

T. Rowe Price Associates’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-44,832
2022 Q3	$82K	Sell	44,832 -74,619
2022 Q2	$376K	Hold	119,451
2022 Q1	$738K	Buy	+119,451
2021 Q4	–	Sell	-24,303
2021 Q3	$194K	Hold	24,303
2021 Q2	$694K	Buy	+24,303